Neumora vs ProJenX
Neumora
Pioneering a new era of medicines for brain diseases
111 employees · est. 2020 · Watertown, United States
ProJenX
ProJenX is a clinical-stage biotech developing novel, brain-penetrant MAP4K inhibitors for ALS & other diseases
9 employees · est. 2021 · New York, United States
Neumora is the older company (2020 vs 2021); Neumora is the larger of the two.
Side-by-Side Comparison
| Metric | Neumora | ProJenX |
|---|---|---|
| Founded | ||
| Founded | 2020 older | 2021 |
| Headquarters | ||
| Headquarters | Watertown, United States | New York, United States |
| Employees | ||
| Employees | 111 larger | 9 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biopharma, Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series B | Series A |
| Total Funding | ||
| Total Funding | $612.00M | $21.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 3 |
| Services | ||
| Services | Development of precision medicines for brain diseases, Drug pipeline targeting novel mechanisms of action, Integration of translational, clinical, and computational tools | Drug Development for ALS, Clinical Trial Execution, Research and Development of Neurodegenerative Therapies, Discovery and Preclinical Testing of Kinase Inhibitors |
| Target Customers | ||
| Target Customers | Patients with brain diseases, Medical professionals in neurology and psychiatry, Healthcare providers focused on CNS disorders | Individuals with Amyotrophic Lateral Sclerosis (ALS), Healthcare Providers in Neurology, Research Institutions Focusing on Neuroscience, Neurodegenerative Disease Community |
| Taxonomy | ||
| Taxonomy | Brain DiseasesNeuroscienceNeuropsychiatric DisordersNeurodegenerative DiseasesPrecision NeuroscienceNovel Mechanisms Of Action +9 | Clinical-stage BiotechnologyNeurodegenerative DiseasesALS TherapyBrain-penetrant TherapiesMAPK TherapeuticsMotor Neuron Degenerative Pathways +7 |
| Website | ||
| Website | neumoratx.com | projenx.com |
About Neumora
Neumora, founded in 2020 in the United States, is a pioneering company in the Biotechnology and Health Care industries, with a mission to redefine treatment methodologies for brain diseases. Operating under the slogan, "Pioneering a new era of medicines for brain diseases," Neumora addresses a criti...
About ProJenX
ProJenX, founded in 2021, is a clinical-stage biotechnology company based in the United States. Specializing in targeted, brain-penetrant treatments for neurodegenerative diseases, it focuses initially on ALS with its lead therapy candidate, prosetin. Emerging from a collaboration with Project ALS...
Also comparing in this category
Comparing more than these two?
Get Neumora, ProJenX and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Neumora compare?
A PDF of Neumora and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Neumora with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Neumora on 9 Jun 2026, and ProJenX on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
